The biology of depression in cancer and the relationship between depression and cancer progression

References

• Abercrombie, H.C., Giese-Davis, J., Sephton, S., Epel, E.S., Turner-Cobb, J.M. & Spiegel, D. (2004). Flattened cortisol rhythms in metastatic breast cancer patients. Psychoneuroendocrinology, 29, 1082–1092.
   PubMed Web of Science ®Google Scholar
• Besedovsky, H., del Rey, A., Sorkin, E. & Dinarello, C.A. (1986). Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science, 233, 652–654.
   PubMed Web of Science ®Google Scholar
• Bierhaus, A., Wolf, J., Andrassy, M., Rohleder, N., Humpert, P.M., Petrov, D., … Nawroth, P.P. (2003). A mechanism converting psychosocial stress into mononuclear cell activation. Proceedings of the National Academy of Sciences of the United States of America, 100, 1920–1925.
   PubMed Web of Science ®Google Scholar
• Bower, J.E., Ganz, P.A., Aziz, N. & Fahey, J.L. (2002). Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosomatic Medicine, 64, 604–611.
   PubMed Web of Science ®Google Scholar
• Bower, J.E., Ganz, P.A., Dickerson, S.S., Petersen, L., Aziz, N. & Fahey, J.L. (2005). Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology, 30, 92–100.
   PubMed Web of Science ®Google Scholar
• Bower, J.E., Ganz, P.A., Irwin, M.R., Arevalo, J.M. & Cole, S.W. (2011). Fatigue and gene expression in human leukocytes: Increased NF-kappa B and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue. Brain, Behavior and Immunity, 25, 147–150.
   PubMedGoogle Scholar
• Bower, J.E., Ganz, P.A., Tao, M.L., Hu, W., Belin, T.R., Sepah, S., … Aziz, N. (2009). Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clinical Cancer Research, 15, 5534–5540.
   PubMed Web of Science ®Google Scholar
• Braunstein, S., Formenti, S.C. & Schenider, R.J. (2008). Acquisition of stable inducible up-regulation of nuclear factor-kappa B by tumor necrosis factor exposure confers increased radiation resistance without increased transformation in breast cancer cells. Molecular Cancer Research, 6, 78–88.
   PubMedGoogle Scholar
• Brown, D.W., Anda, R.F., Tiemeier, H., Felitti, V.J., Edwards, V.J., Croft, J.B. & Giles, W.H. (2009). Adverse childhood experiences and the risk of premature mortality. American Journal of Preventive Medicine, 37, 389–396.
   PubMed Web of Science ®Google Scholar
• Bufalino, C., Hepgul, N., Aguglia, E. & Pariante, C.M. (2012). The role of immune genes in the association between depression and inflammation: A review of recent clinical studies. Brain, Behavior and Immunity, 31, 31–47.
   PubMedGoogle Scholar
• Bull, S.J., Huezo-Diaz, P., Binder, E.B., Cubells, J.F., Ranjith, G., Maddock, C., … Pariante, C.M. (2009). Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Molecular Psychiatry, 14, 1095–1104.
   PubMed Web of Science ®Google Scholar
• Capuron, L. & Dantzer, R. (2003). Cytokines and depression: The need for a new paradigm. Brain, Behavior and Immunity, 17, S19–24.
   Google Scholar
• Capuron, L., Fornwalt, F.B., Knight, B.T., Harvey, P.D., Ninan, P.T. & Miller, A.H. (2009). Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?Journal of Affective Disorders, 199, 181–185.
   Google Scholar
• Capuron, L., Gumnick, J.F., Musselman, D.L., Lawson, D.H., Reemsnyder, A., Nemeroff, C.B. & Miller, A.H. (2002a). Neurobehavioral effects of interferon-alpha in cancer patients: Phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology, 26, 643–652.
   PubMed Web of Science ®Google Scholar
• Capuron, L., Ravaud, A., Neveu, P.J., Miller, A.H., Maes, M. & Dantzer, R. (2002b). Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Molecular Psychiatry, 7, 468–473.
   PubMed Web of Science ®Google Scholar
• Capuron, L., Raison, C.L., Musselman, D.L., Lawson, D.H., Nemeroff, C.B. & Miller, A.H. (2003a). Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. American Journal of Psychiatry, 160, 1342–1345.
   PubMedGoogle Scholar
• Capuron, L., Neurauter, G., Musselman, D.L., Lawson, D.H., Nemeroff, C.B., Fuchs, D. & Miller, A.H. (2003b). Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biological Psychiatry, 54, 906–914.
   PubMed Web of Science ®Google Scholar
• Carney, R.M., Freedland, K.E., Stein, P.K., Miller, G.E., Steinmeyer, B., Rich, M.W. & Duntley, S.P. (2007). Heart rate variability and markers of inflammation and coagulation in depressed patients with coronary heart disease. Journal of Psychosomatic Research, 62, 463–467.
   PubMedGoogle Scholar
• Carpenter, L.L., Gawuga, C.E., Tyrka, A.R., Lee, J.K., Anderson, G.M. & Price, L.H. (2010). Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults. Neuropsychopharmacology, 35, 2617–2623.
   PubMed Web of Science ®Google Scholar
• Cole, S.W. (2009). Chronic inflammation and breast cancer recurrence. Journal of Clinical Oncology, 27, 3418–3419.
   PubMed Web of Science ®Google Scholar
• Costa, D., Mogos, I. & Toma, T. (1985). Efficacy and safety of mianserin in the treatment of depression of women with cancer. Acta Psychiatrica Scandinavica Supplementum, 320, 85–92.
   PubMedGoogle Scholar
• Courtier, N., Gambling, T., Enright, S., Barrett-Lee, P., Abraham, J. & Mason, M.D. (2013). Psychological and immunological characteristics of fatigued women undergoing radiotherapy for early stage breast cancer. Supportive Care in Cancer, 21, 173–181.
   PubMedGoogle Scholar
• Currier, M.B. & Nemeroff, C.B. (2014). Depression as a risk factor for cancer: From pathophysiological advances to treatment implications. Annual Review of Medicine, 65, 9.1–9.19. doi: 10.1146/annurev-med-061212-171507.
   Google Scholar
• Curzon, G. (1975). CSF homovanillic acid: An index of dopaminergic activity. Advances in Neurology, 9, 349–357.
   PubMedGoogle Scholar
• Danese, A., Moffitt, T.E., Pariante, C.M., Ambler, A., Poulton, R. & Caspi, A. (2008). Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Archives of General Psychiatry, 65, 409–415.
   PubMed Web of Science ®Google Scholar
• Danese, A., Pariante, C.M., Caspi, A., Taylor, A. & Poulton, R. (2007). Childhood maltreatment predicts adult inflammation in a life-course study. Proceedings of the National Academy of Sciences of the United States of America, 104, 1319–1324.
   PubMed Web of Science ®Google Scholar
• Dantzer, R. (2001). Cytokine-induced sickness behavior: Mechanisms and implications. Annals of the New York Academy of Sciences, 933, 222–234.
   PubMed Web of Science ®Google Scholar
• Dantzer, R., O’Connor, J.C., Freund, G.G., Johnson, R.W. & Kelley, K.W. (2008). From inflammation to sickness and depression: When the immune system subjugates the brain. Nature Reviews, Neuroscience, 9, 46–56.
   PubMed Web of Science ®Google Scholar
• De Paiva, V.N., Lima, S.N., Fernandes, M.M., Soncini, R., Andrade, C.A., Giusti-Paiva, A. (2010). Prostaglandins mediate depressive-like behavior induced by endotoxin in mice. Behavioural Brain Research, 215, 146–151.
   PubMedGoogle Scholar
• Di Donato, J.A., Mercurio, F. & Karin, M. (2012). NF-kappa B and the link between inflammation and cancer. Immunological Reviews, 246, 379–400.
   PubMed Web of Science ®Google Scholar
• Di Padova, F., Pozzi, C., Tondre, M.J. & Tritapepe, R. (1991). Selective and early increase of IL-1 inhibitors, IL-6 and cortisol after elective surgery. Clinical and Experimental Immunology, 85, 137–142.
   PubMed Web of Science ®Google Scholar
• Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E.K. & Lanctot, K.L. (2010). A meta-analysis of cytokines in major depression. Biological Psychiatry, 67, 446–457.
   PubMed Web of Science ®Google Scholar
• Dunn, A.J., Wang, J. & Ando, T. (1999). Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Advances in Experimental Medicine and Biology, 461, 117–1127.
   PubMed Web of Science ®Google Scholar
• Eisenberger, N.I., Berkman, E.T., Inagaki, T.K., Ramseson, L.T., Mashal, N.M. & , Irwin, M.R. (2010a). Inflammation-induced anhedonia: Endotoxin reduces ventral striatum responses to reward. Biological Psychiatry, 68, 748–754.
   PubMed Web of Science ®Google Scholar
• Eisenberger, N.I., Inagaki, T.K., Rameson, L.T., Mashal, N.M. & Irwin, M.R. (2009). An fMRI study of cytokine-induced depressed mood and social pain: The role of sex differences. Neuroimage, 47, 881–890.
   PubMed Web of Science ®Google Scholar
• Evans, D.L., McCartney, C.F., Haggerty, J.J. Jr, Nemeroff, C.B., Golden, R.N., Simon, J.B., … Mason, G.A. (1988). Treatment of depression in cancer patients is associated with better life adaptation: A pilot study. Psychosomatic Medicine, 50, 73–76.
   PubMedGoogle Scholar
• Falagas, M.E., Zarkadoulia, E.A., Ioannidou, E.N., Peppas, G., Christodoulou, C. & Rafailidis, P.I. (2007). The effect of psychosocial factors on breast cancer outcome: A systematic review. Breast Cancer Research, 9, R44.
   PubMed Web of Science ®Google Scholar
• Faller, H., Bülzebruck, H., Drings, P. & Lang, H. (1999). Coping, distress, and survival among patients with lung cancer. Archives of General Psychiatry, 56, 756–762.
   PubMed Web of Science ®Google Scholar
• Fallowfield, L.J. (1990). Psychosocial adjustment after treatment for early breast cancer. Oncology (Williston Park, NY), 4, 89–97; discussion, 97–98.
   PubMedGoogle Scholar
• Fann, J.R., Thomas-Rich, A.M., Katon, W.J., Cowley, D., Pepping, M., McGregor, B.A. & Gralow, J. (2008). Major depression after breast cancer: A review of epidemiology and treatment. General Hospital Psychiatry, 30, 112–126.
   PubMed Web of Science ®Google Scholar
• Fawzy, F.I., Fawzy, N.W., Hyun, C.S., Elashoff, R., Guthrie, D., Fahey, J.L. & Morton, D.L. (1993). Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Archives of General Psychiatry, 50, 681–689.
   PubMed Web of Science ®Google Scholar
• Fawzy, F.I., Cousins, N., Fawzy, N.W., Kemeny, M.E., Elashoff, R. & Morton, D. (1990a). A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance.Archives of General Psychiatry, 47, 720–725.
   PubMed Web of Science ®Google Scholar
• Fawzy, F.I., Kemeny, M.E., Fawzy, N.W., Elashoff, R., Morton, D., Cousins, N. & Fahey, J.L. (1990b). A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures. Archives of General Psychiatry, 47, 729–735.
   PubMed Web of Science ®Google Scholar
• Filipski, E. & Levi, F. (2009). Circadian disruption in experimental cancer processes. Integrative Cancer Therapies, 8, 298–302.
   PubMed Web of Science ®Google Scholar
• Fitzgerald, P., O’Brien, S.M., Scully, P., Rijkers, K., Scott, L.V. & Dinan, T.G. (2006). Cutaneous glucocorticoid receptor sensitivity and proinflammatory cytokine levels in antidepressant-resistant depression. Psychological Medicine, 36, 37–43.
   PubMed Web of Science ®Google Scholar
• Frasure-Smith, N., Lesperance, F., Irwin, M.R., Talajic, M. & Pollock, B.G. (2009). The relationship among heart rate variability, inflammatory markers and depression in coronary heart disease patients. Brain, Behavior, and Immunity, 23, 1140–1147.
   PubMed Web of Science ®Google Scholar
• Giese-Davis, J., Collie, K., Rancourt, K.M., Neri, E., Kraemer, H.C. & Spiegel, D. (2011). Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: A secondary analysis. Journal of Clinical Oncology, 29, 413–420.
   PubMed Web of Science ®Google Scholar
• Greenberg, D.B., Gray, J.L., Mannix, C.M., Eisenthal, S. & Carey, M. (1993). Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer. Journal of Pain and Symptom Management, 8, 196–200.
   PubMed Web of Science ®Google Scholar
• Hernandez-Vargas, H., Rodriguez-Pinilla, S.M., Julian-Tendero, M., Sanchez Rovira, P., Cuevas, C., Anton, A., … Moreno-Bueno, G. (2007). Gene expression profiling of breast cancer cells in response to gemcitabine: NF-κB pathway activation as a potential mechanism of resistance. Brain Cancer Research and Treatment, 102, 157–172.
   PubMedGoogle Scholar
• Holland, J.C., Romano, S.J., Heiligenstein, J.H., Tepner, R.G., Wilson, M.G. (1998). A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psychooncology, 7, 291–300.
   PubMed Web of Science ®Google Scholar
• Holsboer, F. & Barden, N. (1996). Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocrine Reviews, 17, 187–205.
   PubMed Web of Science ®Google Scholar
• Irwin, M.R., Olmstead, R., Valladares, E.M., Breen, E.C. & Ehlers, C.L. (2009). Tumor necrosis factor antagonism normalizes rapid eye movement sleep in alcohol dependence. Biological Psychiatry, 66, 191–195.
   PubMed Web of Science ®Google Scholar
• Irwin, M.R., Wang, M., Ribeiro, D., Cho, H.J., Olmstead, R., Breen, E.C., … Cole, S. (2008). Sleep loss activates cellular inflammatory signaling. Biological Psychiatry, 64, 538–540.
   PubMed Web of Science ®Google Scholar
• Jakeways, M.S., Mitchell, V., Hashim, I.A., Chadwick, S.J., Shenkin, A., Green, C.J. & Carli, F. (1994). Metabolic and inflammatory responses after open or laparoscopic cholecystectomy. British Journal of Surgery, 81, 127–131.
   PubMed Web of Science ®Google Scholar
• Jeannin, P., Duluc, D. & Delneste, Y. (2011). IL-6 and leukemia inhibitory factor are involved in the generation of tumor-associated macrophage: Regulation by IFN-gamma. Immunotherapy, 3, 23–26.
   PubMedGoogle Scholar
• Jehn, C.F., Kuhnhardt, D., Bartholomae, A., Pfeiffer, S., Schmid, P., Possinger, K., … Luftner, D. (2010). Association of IL-6, hypothalamic–pituitary–adrenal axis function, and depression in patients with cancer. Integrative Cancer Therapies, 9, 270–275.
   PubMedGoogle Scholar
• Johnson, J.D., Campisi, J., Sharkey, C.M., Kennedy, S.L., Nickerson, M., Greenwood, B.N. & Fleshner, M. (2005). Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience, 135, 1295–1307.
   PubMed Web of Science ®Google Scholar
• Juengling, F.D., Ebert, D., Gut, O., Engelbrecht, M.A., Rasenack, J., Nitzsche, E.U., … Lieb, K. (2000). Prefrontal cortical hypometabolism during low-dose interferon alpha treatment. Psychopharmacology, 152, 383–389.
   PubMed Web of Science ®Google Scholar
• Kent, S., Bluthe, R.M., Kelley, K.W. & Dantzer, R. (1992). Sickness behavior as a new target for drug development. Trends in Pharmacological Sciences, 13, 24–28.
   PubMed Web of Science ®Google Scholar
• Kiecolt-Glaser, J.K. & Glaser, R. (2002). Depression and immune function: Central pathways to morbidity and mortality. Journal of Psychosomatic Research, 53, 873–876.
   PubMed Web of Science ®Google Scholar
• Koenig, H.G., Shelp, F., Goli, V., Cohen, H.J. & Blazer, D.G. (1989). Survival and health care utilization in elderly medical inpatients with major depression. Journal of the American Geriatrics Society, 37, 599–606.
   PubMed Web of Science ®Google Scholar
• Koenig, H.G., Cohen, H.J., Blazer, D.G., Meador, K.G. & Westlund, R. (1992). A brief depression scale for use in the medically ill. International Journal of Psychiatry in Medicine, 22, 183–195.
   PubMed Web of Science ®Google Scholar
• Koo, J.W. & Duman, R.S. (2009). Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory. Neuroscience Letters, 456, 39–43.
   PubMedGoogle Scholar
• Krishnan, R., Cella, D., Leonardi, C., Papp, K., Gottlieb, A.B., Dunn, M., … Jahreis, A. (2007). Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque plaque psoriasis for up to 96 weeks. British Journal of Dermatology, 157, 1275–1277.
   PubMed Web of Science ®Google Scholar
• Kristiansson, M., Saraste, L., Soop, M., Sundqvist, K.G. & Thörne, A. (1999). Diminished interleukin-6 and C-reactive protein responses to laparoscopic versus open cholecystectomy. Acta Anaesthesiologica Scandinavica, 43, 146–152.
   PubMed Web of Science ®Google Scholar
• Kruimel, J.W., Pesman, G.J., Sweep, C.G., van der Vliet, J.A., Liem, T., Jansen, J., … Naber, A.H. (1999). Depression of plasma levels of cytokines and ex-vivo cytokine production in relation to the activity of the pituitary-adrenal axis, in patients undergoing major vascular surgery. Cytokine, 11, 382–388.
   PubMedGoogle Scholar
• Kudoh, A., Katagai, H. & Takazawa, T. (2001). Plasma inflammatory cytokine response to surgical trauma in chronic depressed patients. Cytokine, 13, 104–108.
   PubMedGoogle Scholar
• Lamkin, D.M., Lutgendorf, S.K., Lubaroff, D., Sood, A.K., Beltz, T.G. & Johnson, A.K. (2011). Cancer induces inflammation and depressive-like behavior in the mouse: Modulation by social housing. Brain, Behavior, and Immunity, 25, 555–564.
   PubMed Web of Science ®Google Scholar
• Lane, D., Matte, I., Rancourt, C. & Piche, A. (2011). Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients. BMC Cancer, 11, 210.
   PubMed Web of Science ®Google Scholar
• Lanquillon, S., Krieg, J.C., Bening-Abu-Shach, U. & Vedder, H. (2000). Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology, 22, 370–379.
   PubMed Web of Science ®Google Scholar
• Lestage, J., Verrier, D., Palin, K. & Dantzer, R. (2002). The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. Brain, Behavior, and Immunity, 16, 596–601.
   PubMed Web of Science ®Google Scholar
• Li, H., Ruan, X.Z., Powis, S.H., Fernando, R., Mon, W.Y., Wheeler, D.C., … Varghese, Z. (2005). EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: Evidence for a PPAR-gamma-dependent mechanism. Kidney International, 67, 867–874.
   PubMed Web of Science ®Google Scholar
• Liebau, C., Merk, H., Schmidt, S., Roesel, C., Karreman, C., Prisack, J.B., … Baltzer, A.W. (2002). Interleukin-12 and interleukin-18 change ICAM-I expression, and enhance natural killer cell mediated cytolysis of human osteosarcoma cells. Cytokines, Cellular and Molecular Therapy, 7, 135–142.
   PubMed Web of Science ®Google Scholar
• Lin, P.Y., Huang, S.Y. & Su, K.P. (2010). A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biological Psychiatry, 68, 140–147.
   PubMed Web of Science ®Google Scholar
• Lindqvist, D., Janelidze, S., Hagell, P., Erhardt, S., Samuelsson, M., Minthon, L., … Brundin, L. (2009). Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biological Psychiatry, 66, 287–292.
   PubMed Web of Science ®Google Scholar
• Liu, L., Mills, P.J., Rissling, M., Fiorentino, L., Natarajan, L., Dimsdale, J.E., … Ancoli-Israel, S. (2012a). Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy. Brain, Behavior, and Immunity, 26, 706–713.
   PubMed Web of Science ®Google Scholar
• Liu, L., Rissling, M., Natarajan, L., Fiorentino, L., Mills, P.J., Dimsdale, J.E., … Ancoli-Israel S. (2012b). The longitudinal relationship between fatigue and sleep in breast cancer patients undergoing chemotherapy. Sleep, 35, 237–245.
   PubMed Web of Science ®Google Scholar
• Loprinzi, C.L., Kugler, J.W., Sloan, J.A., Mailliard, J.A., LaVasseur, B.I., Barton, D.L., … Christensen, B.J. (2000). Venlafaxine in management of hot flashes in survivors of breast cancer: A randomised controlled trial. Lancet, 356, 2059–2063.
   PubMed Web of Science ®Google Scholar
• Loprinzi, C.L., Sloan, J.A., Perez, E.A., Quella, S.K., Stella, P.J., Mailliard, J.A., … Rummans T.A. (2002). Phase III evaluation of fluoxetine for treatment of hot flashes. Journal of Clinical Oncology, 20, 1578–1583.
   PubMed Web of Science ®Google Scholar
• Lutgendorf, S.K., Weinrib, A.Z., Penedo, F., Russell, D., DeGeest, K., Costanzo, E.S., … Lubaroff, D.M. (2008). Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients. Journal of Clinical Oncology, 26, 4820–4827.
   PubMed Web of Science ®Google Scholar
• Madhusudan, S., Foster, M., Muthuramalingam, S.R., Braybrooke, J.P., Wilner, S., Kaur, K., … Harris, A.L. (2004). A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer. Clinical Cancer Research, 10, 6528–6534.
   PubMed Web of Science ®Google Scholar
• Madhusudan, S., Muthuramalingam, S.R., Braybrooke, J.P., Wilner, S., Kaur, K., Han, C., … Ganesan, T.S. (2005). Study of etanercept, a tumor necrosis alpha inhibitor, in recurrent ovarian cancer. Journal of Clinical Oncology, 23, 5950–5959.
   PubMed Web of Science ®Google Scholar
• Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. (2008). Cancer-related inflammation. Nature, 454, 436–444.
   PubMed Web of Science ®Google Scholar
• Massie, M.J. (2004). Prevalence of depression in patients with cancer. Journal of the National Cancer Institute Monographs, 32, 57–71.
   PubMedGoogle Scholar
• Mathias, S.D., Colwell, H.H., Miller, D.P., Moreland, L.W., Buatti, M. & Wanke, L. (2000). Health-related quality of life and functional status of patients with rheumatoid arthritis randomly assigned to receive etanercept or placebo. Clinical Therapeutics, 22, 128–139.
   PubMed Web of Science ®Google Scholar
• Max, M.B., Lynch, S.A., Muir, J., Shoaf, S.E., Smoller, B. & Dubner, R. (1992). Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine, 326, 1250–1256.
   PubMed Web of Science ®Google Scholar
• Mazzeo, R.S., Donovan, D., Fleshner, M., Butterfield, G.E., Zamudio, S., Wolfel, E.E. & Moore, L.G. (2001). Interleukin-6 response to exercise and high-altitude exposure: Influence of alpha-adrenergic blockade. Journal of Applied Physiology, 91, 2143–2149.
   PubMed Web of Science ®Google Scholar
• McDaniel, J.S., Musselman, D.L., Porter, M.R., Reed, D.A. & Nemeroff, C.B. (1995). Depression in patients with cancer. Diagnosis, biology, and treatment. Archives of General Psychiatry, 52, 89–99.
   PubMed Web of Science ®Google Scholar
• McGee, R., Williams, S. & Elwood, M. (1994). Depression and the development of cancer: A meta-analysis. Social Science and Medicine, 38, 187–192.
   PubMed Web of Science ®Google Scholar
• McKenna, M.C., Zevon, M.A., Corn, B. & Rounds, J. (1999). Psychosocial factors and the development of breast cancer: A meta-analysis. Health Psychology, 18, 520–531.
   PubMed Web of Science ®Google Scholar
• Mehta, D., Raison, C.L., Woolwine, B.J., Haroon, E., Binder, E.B., Miller, A.H. & Felger, J.C. (2013). Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression. Brain, Behavior, and Immunity, 31, 205–215.
   PubMedGoogle Scholar
• Melhem, A., Yamada, S.D., Fleming, G.F., Delgado, B., Brickley, D.R., Wu, W., … Conzen, S.D. (2009). Administration of glucocorticoids to ovarian cancer patients is associated with expression of the anti-apoptotic genes SGK1 and MKP1/DUSP1 in ovarian tissues. Clinical Cancer Research, 15, 3196–3204.
   PubMed Web of Science ®Google Scholar
• Mendlewicz, J., Kriwin, P., Oswald, P., Souery, D., Alboni, S. & Brunello, N. (2006). Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: A pilot open label study. International Clinical Psychopharmacology, 21, 227–231.
   PubMed Web of Science ®Google Scholar
• Merali, Z., Du, L., Hrdina, P., Palkovits, M., Faludi, G., Poulter, M.O. & Anisman, H. (2004). Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical region. Journal of Neuroscience, 24, 1478–1485.
   PubMed Web of Science ®Google Scholar
• Meyers, C.A., Albitar, M. & Estey, E. (2005). Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer, 104, 788–793.
   PubMed Web of Science ®Google Scholar
• Miller, A.H., Ancoli-Israel, S., Bower, J.E., Capuron, L. & Irwin, M.R. (2008). Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. Journal of Clinical Oncology, 26, 971–982.
   PubMed Web of Science ®Google Scholar
• Miller, A.H., Maletic, V. & Raison, C.L. (2009). Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biological Psychiatry, 65, 732–741.
   PubMed Web of Science ®Google Scholar
• Mills, P.J., Ancoli-Israel, S., Parker, B., Natarajan, L., Hong, S., Jain, S., … von Känel, R. (2008). Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer. Brain, Behavior, and Immunity, 22, 98–104.
   PubMed Web of Science ®Google Scholar
• Mills, P.J. & Dimsdale, J.E. (2004). Sleep apnea: A model for studying cytokines, sleep, and sleep disruption. Brain, Behavior, and Immunity, 18, 298–303.
   PubMed Web of Science ®Google Scholar
• Mizoi, Y., Kaneko, H., Oharazawa, A. & Kuroiwa, H. (1997). Parkinsonism in a patient receiving interferon alpha therapy for chronic hepatitis C. [in Japanese]. Rinsho Shinkeigaku, 37, 54–56.
   PubMedGoogle Scholar
• Monk, J.P., Phillips, G., Waite, R., Kuhn, J., Schaaf, L.J., Otterson, G.A., … Villalona-Calero, M.A. (2006). Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients. Journal of Clinical Oncology, 24, 1852–1859.
   PubMed Web of Science ®Google Scholar
• Mormont, M.C. & Levi, F. (1997). Circadian-system alterations during cancer processes: A review. International Journal of Cancer, 70, 241–247.
   PubMed Web of Science ®Google Scholar
• Motivala, S.J., Sarfatti, A., Olmos, L. & Irwin, M.R. (2005). Inflammatory markers and sleep disturbance in major depression. Psychosomatic Medicine, 67, 187–194.
   PubMed Web of Science ®Google Scholar
• Muller, N., Schwarz, M.J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Muller, B., … Riedel, M. (2006). The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: Results of a double-blind, randomized, placebo-controlled, add-on pilot study to reboxetine. Molecular Psychiatry, 11, 680–684.
   PubMed Web of Science ®Google Scholar
• Murumkar, P.R., DasGupta, S., Chandani, S.R., Giridhar, R. & Yadav, M.R. (2010). Novel TACE inhibitors in drug discovery: A review of patented compounds. Expert Opinion on Therapeutic Patents, 20, 31–57.
   PubMed Web of Science ®Google Scholar
• Musselman, D.L., Lawson, D.H., Gumnick, J.F., Manatunga, A.K., Penna, S., Goodkin, R.S., … Miller, A.H. (2001a). Paroxetine for the prevention of depression induced by high-dose interferon alfa. New England Journal of Medicine, 344, 961–966.
   PubMed Web of Science ®Google Scholar
• Musselman, D.L., Miller, A.H., Porter, M.R., Manatunga, A., Gao, F., Penna, S., … Nemeroff, C.B. (2001b). Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: Preliminary findings. American Journal of Psychiatry, 158, 1252–1257.
   PubMed Web of Science ®Google Scholar
• Musselman, D.L., Roysrer, E.B., Wang, M., Long, Q., Trimble, L.M., Mann, T.K., … Miller, A.H. (2013). The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: Preliminary findings. Neuropsychopharmacology, 38(10), 1921–1928. doi:10.1038/npp.2013.85
   PubMedGoogle Scholar
• Nicolson, S.E., Miller, A.H., Lawson, D. & Musselman, D.L. (2006). Neuropsychiatric effects of IL-2: Mechanisms and treatment implications. Depression: Mind and Body, 2, 120–129.
   Google Scholar
• Nilsson, M.B., Langley, R.R. & Fidler, I.J. (2005). Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine. Cancer Research, 65, 10794–10800.
   PubMed Web of Science ®Google Scholar
• Obata, N.H., Tamakoshi, K., Shibata, K., Kikkawa, F. & Tomoda, Y. (1997). Effects of interleukin-6 on in vitro cell attachment, migration, and invasion of human ovarian carcinoma. Anticancer Research, 17, 337–342.
   PubMed Web of Science ®Google Scholar
• Offner, F.A., Obrist, P., Stadlmann, S., Feichtinger, H., Klinger, P., Herold, M., … Marth, C. (1995). IL-6 secretion by human peritoneal mesothelial and ovarian cancer cells. Cytokine, 7, 542–547.
   PubMedGoogle Scholar
• Omne-Pontén, M., Holmberg, L., Burns, T., Adami, H.O. & Bergström, R. (1992). Determinants of the psycho-social outcome after operation for breast cancer. Results of a prospective comparative interview study following mastectomy and breast conservation. European Journal of Cancer, 28A, 1062–1067.
   Google Scholar
• Owens, M.J. & Nemeroff, C.B. (1991). Physiology and pharmacology of corticotropin-releasing factor. Pharmacological Reviews, 43, 425–473.
   PubMed Web of Science ®Google Scholar
• Owens, M.J. & Nemeroff, C.B. (1993). The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: Laboratory and clinical studies. Ciba Foundation Symposium, 172, 296–308; discussion, 308–316.
   PubMedGoogle Scholar
• Pace, T.W., Mletzko, T.C., Alagbe, O., Musselman, D.L., Nemeroff, C.B., Miller, A.H. & Heim, C.M. (2006). Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. American Journal of Psychiatry, 163, 1630–1633.
   PubMed Web of Science ®Google Scholar
• Pagnoni, G., Zink, C.F., Montague, P.R. & Berns, G.S. (2002). Activity in human ventral striatum locked to errors of reward prediction. Nature Neuroscience, 5, 97–98.
   PubMed Web of Science ®Google Scholar
• Palesh, O., Zeitzer, J.M., Conrad, A., Giese-Davis, J., Mustian, K.M., Popek, V., … Spiegel, D. (2008). Vagal regulation, cortisol, and sleep disruption in women with metastatic breast cancer. Journal of Clinical Sleep Medicine, 4, 441–449.
   PubMed Web of Science ®Google Scholar
• Pan, D., Kocherginsky, M. & Conzen, S.D. (2011). Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer. Cancer Research, 71, 6360–6370.
   PubMed Web of Science ®Google Scholar
• Pang, D., Kocherginsky, M., Krausz, T., Kim, S.Y. & Conzen, S.D. (2006). Dexamethasone decreases xenograft response to paclitaxel through inhibition of tumor cell apoptosis. Cancer Biology and Therapy, 58, 933–940.
   Google Scholar
• Papanicolaou, D.A. (2000). Euthyroid sick syndrome and the role of cytokines. Reviews in Endocrine and Metabolic Disorders, 1, 43–48.
   PubMedGoogle Scholar
• Pariante, C.M. & Miller, A.H. (2001). Glucocorticoid receptors in major depression: Relevance to pathophysiology and treatment. Biological Psychiatry, 49, 391–404.
   PubMed Web of Science ®Google Scholar
• Pelletier, G., Verhoef, M.J., Khatri, N. & Hagen, N. (2002). Quality of life in brain tumor patients: The relative contributions of depression, fatigue, emotional distress, and existential issues. Journal of Neurooncology, 57, 41–49.
   PubMed Web of Science ®Google Scholar
• Pezzella, G., Moslinger-Gehmayr, R. & Contu, A. (2001). Treatment of depression in patients with breast cancer: A comparison between paroxetine and amitriptyline. Breast Cancer Research and Treatment, 70, 1–10.
   PubMedGoogle Scholar
• Pirl, W.F., Greer, J.A., Traeger, L., Jackson, V., Lennes, I.T., Gallagher, R., … Temel, J.S. (2012). Depression and survival in metastatic non-small-cell lung cancer: Effects of early palliative care. Journal of Clinical Oncology, 30, 1310–1315.
   PubMed Web of Science ®Google Scholar
• Plante, M., Rubin, S.C., Wong, G.Y., Federici, M.G., Finstad, C.L. & Gastl, G.A. (1994). Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer. Cancer, 73, 1882–1888.
   PubMed Web of Science ®Google Scholar
• Plotkin, S.R., Banks, W.A. & Kastin, A.J. (1996). Comparison of saturable transport and extracellular pathways in the passage of interleukin-1 alpha across the blood brain barrier. Journal of Neuroimmunology, 67, 41–47.
   PubMed Web of Science ®Google Scholar
• Polsky, D., Doshi, J.A., Marcus, S., Oslin, D., Rothbard, A., Thomas, N. & Thompson, C.L. (2005). Long-term risk for depressive symptoms after a medical diagnosis. Archives of Internal Medicine, 165, 1260–1266.
   PubMed Web of Science ®Google Scholar
• Pyter, L.M., Pineros, V., Galang, J.A., McClintock, M.K. & Prendergast, B.J. (2009). Peripheral tumors induce depressive-like behaviors and cytokine production and alter hypothalamic–pituitary–adrenal axis regulation. Proceedings of the National Academy of Sciences of the United States of America, 106, 9069–9074.
   PubMed Web of Science ®Google Scholar
• Rae, M.T. & Hillier, S.G. (2005). Steroid signaling in the ovarian surface epithelium. Trends in Endocrinology and Metabolism, 16, 327–333.
   PubMed Web of Science ®Google Scholar
• Raison, C.L., Borisov, A.S., Broadwell, S.D., Capuron, L., Woolwine, B.J., Jacobson, I.M., … Miller, A.H. (2005a). Depression during pegylated interferon-alpha plus ribavirin therapy: Prevalence and prediction. Journal of Clinical Psychiatry, 66, 41–48.
   PubMed Web of Science ®Google Scholar
• Raison, C.L., Dantzer, R., Kelley, K.W., Lawson, M.A., Woolwine, B.J., Vogt, G., … Miller AH. (2010). CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: Relationship to CNS immune responses and depression. Molecular Psychiatry, 15, 393–403.
   PubMed Web of Science ®Google Scholar
• Raison, C.L., Demetrashvii, M.F., Capuron, L. & Miller, A.H. (2005b). Neuropsychiatric adverse effects of interferon-alpha: Recognition and management. CNS Drugs, 19, 105–123.
   PubMed Web of Science ®Google Scholar
• Raison, C.L. & Miller, A.H. (2003). Depression in cancer: New developments regarding diagnosis and treatment. Biological Psychiatry, 54, 283–294.
   PubMed Web of Science ®Google Scholar
• Raison, C.L., Woolwine, B.J., Demetrashvii, M.F., Borisov, A.S., Weinreib, R., Staab, J.P., … Miller, A.H. (2007). Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C. Alimentary Pharmacology and Therapeutics, 25, 1163–1174.
   PubMed Web of Science ®Google Scholar
• Raison, C.L., Rutherford, R.E., Woolwine, B.J., Shuo, C. Schettler, P., … Miller, A.H. (2013). A randomized control trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory markers. JAMA Psychiatry, 70, 31–41.
   PubMed Web of Science ®Google Scholar
• Razavi, D., Allilaire, J.F., Smith, M., Salimpour, A., Verra, M., Desclaux, B., … Blin, P. (1996). The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatrica Scandinavica, 94, 205–210.
   PubMed Web of Science ®Google Scholar
• Rivest, S., Lacroix, S., Vallieres, L., Nadeau, S., Zhang, J. & Laflamme, N. (2000). How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli. Proceedings of the Society for Experimental Biology and Medicine, 223, 22–38.
   PubMed Web of Science ®Google Scholar
• Rivier, C. (1995). Influence of immune signals on the hypothalamic–pituitary axis of the rodent. Frontiers in Neuroendocrinology, 16, 151–182.
   PubMedGoogle Scholar
• Rooney, A.G., McNamara, S., Mackinnon, M., Fraser, M., Rampling, R., Carson, A. & Grant, R. (2011). Frequency, clinical associations, and longitudinal course of major depressive disorder in adults with cerebral glioma. Journal of Clinical Oncology, 29, 4307–4312.
   PubMedGoogle Scholar
• Roscoe, J.A., Morrow, G.R., Hickok, J.T., Mustian, K.M., Griggs, J.J., Matteson, S.E., … Smith, B. (2005). Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Research Treatment, 89, 243–249.
   PubMed Web of Science ®Google Scholar
• Ross, L., Boesen, E.H., Dalton, S.O. & Johansen, C. (2002). Mind and cancer: Does psychosocial intervention improve survival and psychological well-being?European Journal of Cancer, 38, 1447–1457.
   PubMed Web of Science ®Google Scholar
• Sarasombath, P., Sumida, K. & Kaku, D.A. (2002). Parkinsonism associated with interferon alpha therapy for chronic myelogenous leukemia. Hawaii Medical Journal, 61(3): 48–57.
   PubMedGoogle Scholar
• Satin, J.R., Linden, W. & Phillips, M.J. (2009). Depression as a predictor of disease progression and mortality in cancer patients: A meta-analysis. Cancer, 115, 5349–5361.
   PubMed Web of Science ®Google Scholar
• Savas, S., Hyde, A., Stuckless, S.N., Parfrey, P., Banfield Younghusband, H. & Green, R. (2012). Serotonin transporter gene (SLC6A4) variations are associated with poor survival in colorectal cancer patients. PLOS ONE, 7, e38953.
   Google Scholar
• Scambia, G., Testa, U., Panici, P.B., Foti, E., Martucci, R., Gaducci, A., … Mancuso, S. (1995). Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer. British Journal of Cancer, 71, 354–356.
   PubMed Web of Science ®Google Scholar
• Schlossmacher, G., Stevens, A. & White, A. (2011). Glucocorticoid receptor-mediated apoptosis: Mechanisms of resistance in cancer cells. Journal of Endocrinology, 211, 17–25.
   PubMedGoogle Scholar
• Schrepf, A., Clevenger, L., Christensen, D., DeGeest, K., Bender, D., Ahmed, A., … Lutgendorf, S.K. (2013). Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: Relationships with depression, fatigue, and disability. Brain, Behavior, and Immunity, 30, S126–S134.
   PubMed Web of Science ®Google Scholar
• Semenchuk, M.R., Sherman, S. & Davis, B. (2001). Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain. Neurology, 57, 1583–1588.
   PubMed Web of Science ®Google Scholar
• Sephton, S.E., Sapolsky, R.M., Kraemer, H.C. & Spiegel, D. (2000). Diurnal cortisol rhythm as a predictor of breast cancer survival. Journal of the National Cancer Institute, 92, 994–1000.
   PubMed Web of Science ®Google Scholar
• Simen, B.B., Duman, C.H., Simen, A.A. & Duman, R.S. (2006). TNF alpha signaling in depression and anxiety: Behavioral consequences of individual receptor targeting. Biological Psychiatry, 59, 775–785.
   PubMed Web of Science ®Google Scholar
• Sluzewska, A., Sobieska, M. & Rybakowski, J.K. (1997). Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression. Neuropsychobiology, 35, 123–127.
   PubMed Web of Science ®Google Scholar
• Spiegel, D., Bloom, J.R., Kraemer, H.C. & Gottheil, E. (1989). Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet, 2, 888–891.
   PubMed Web of Science ®Google Scholar
• Stearns, V., Isaacs, C., Rowland, J., Crawford, J., Ellis, M.J., Kramer, R., … Hayes, D.F. (2000). A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Annals of Oncology, 11, 17–22.
   PubMed Web of Science ®Google Scholar
• Stommel, M., Given, B.A. & Given, C.W. (2002). Depression and functional status as predictors of death among cancer patients. Cancer, 94, 2719–2727.
   PubMed Web of Science ®Google Scholar
• Stoudemire, A. & Thompson, T.L. II. (1983). Medication noncompliance: Systematic approaches to evaluation and intervention. General Hospital Psychiatry, 5, 233–239.
   PubMed Web of Science ®Google Scholar
• Su, K.P., Huang, S.Y., Peng, C.Y., Lai, H.C., Huang, C.L., Chen, Y.C., … Pariante, C.M. (2010). Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon- alpha-induced depression by regulating polyunsaturated fatty acids levels. Biological Psychiatry, 67, 550–557.
   PubMed Web of Science ®Google Scholar
• Su, S., Zhao, J., Bremner, J.D., Miller, A.H. & Tang, W. (2009). Serotonin transporter gene, depressive symptoms, and interleukin-6. Circulation: Cadiovascular Genetics, 2(6), 614–620.
   PubMedGoogle Scholar
• Sumpton, J.E. & Moulin, D.E. (2001). Treatment of neuropathic pain with venlafaxine. Annals of Pharmacotherapy, 35, 557–559.
   PubMed Web of Science ®Google Scholar
• Sunami, M., Nishikawa, T., Yorogi, A. & Shimoda, M. (2000). Intravenous administration of levodopa ameliorated a refractory akathisia case induced by interferon-alpha. Clinical Neuropharmacology, 23, 59–61.
   PubMed Web of Science ®Google Scholar
• Teeling, J.L., Cunningham, C., Newman, T.A. & Perry, V.H. (2010). The effect of nonsteroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: Implications for a role of COX-1. Brain, Behavior, and Immunity, 24, 409–419.
   PubMed Web of Science ®Google Scholar
• Thayer, J.F. & Fischer, J.E. (2009). Heart rate variability, overnight urinary norepinephrine and C-reactive protein: evidence for the cholinergic anti-inflammatory pathway in healthy human adults. Journal of Internal Medicine, 265, 439–447.
   PubMed Web of Science ®Google Scholar
• Torres, M.A., Pace, T.W., Liu, T., Felger, J.C., Mister, D., Doho, G.H., … Miller, A.H. (2013). Predictors of depression in breast cancer patients treated with radiation: Role of prior chemotherapy and nuclear factor kappa B. Cancer, 119, 1951–1959.
   PubMed Web of Science ®Google Scholar
• Touitou, Y., Bogdan, A., Levi, F., Benavides, M. & Auzeby, A. (1996). Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: Relationships with tumour marker antigens. British Journal of Cancer, 748, 1248–1252.
   Google Scholar
• Tracey, K.J. (2009). Reflex control of immunity. Nature Reviews Immunology, 9, 418–428.
   PubMed Web of Science ®Google Scholar
• Tyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., … Krishnan, R. (2006). Etanercept and clinical outcomes, fatigue, and depression in psoriasis: Double-blind placebo-controlled randomized phase III trial. Lancet, 367, 29–35.
   PubMed Web of Science ®Google Scholar
• van Heeringen, K. & Zivkov, M. (1996). Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin.British Journal of Psychiatry, 169, 440–443.
   PubMedGoogle Scholar
• Wang, X.S., Shi, Q., Williams, L.A., Mao, L., Cleeland, C.S., Komaki, R.R., … Liao, Z. (2010). Inflammatory cytokines are associated with the development of increased symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain, Behavior, and Immunity, 24, 968–974.
   PubMed Web of Science ®Google Scholar
• Warner-Schmidt, J.L., Vanover, K.E., Chen, E.Y., Marshall, J.J. & Greengard, P. (2011). Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proceedings of the National Academy of Sciences of the United States of America, 108(22), 9262–9267.
   PubMedGoogle Scholar
• Watkins, L.R., Goehler, L.E., Relton, J.K., Tartaglia, N., Silbert, L., Martin, D. & Maier, S.F. (1995). Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication.Neuroscience Letters, 183, 27–31.
   PubMed Web of Science ®Google Scholar
• Watson, J.M., Sensintaffar, J.L., Berek, J.S. & Martínez-Maza, O. (1990). Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Research, 50, 6959–6965.
   PubMed Web of Science ®Google Scholar
• Weinrib, A.Z., Sephton, S.E., DeGeest, K., Penedo, F., Bender, D., Zimmerman, B., … Lutgendorf, S.K. (2010). Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer. Cancer, 116, 4410–4419.
   PubMed Web of Science ®Google Scholar
• Wratten, C., Kilmurray, J., Nash, S., Seldon, M., Hamilton, C.S., O’Brien, P.C., … Denham, J.W. (2004). Fatigue during breast radiotherapy and its relationship to biological factors. International Journal of Radiation Oncology, Biology, Physics, 59, 160–167.
   PubMed Web of Science ®Google Scholar
• Yirmiya, R., Weidenfeld, J., Pollak, Y., Morag, M., Morag, A., Avitsur, R., … Ovadia, H. (1999). Cytokines, ‘depression due to a general medical condition’, and antidepressant drugs. Advances in Experimental Medicine and Biology, 461, 283–316.
   PubMed Web of Science ®Google Scholar
• Zebrack, B.J., Zeltzer, L.K., Whitton, J., Mertens, A.C., Odom, L., Berkow, R. & Robison, L.L. (2002). Psychological outcomes in long-term survivors of childhood leukemia, Hodgkin's disease, and non-Hodgkin's lymphoma: A report from the Childhood Cancer Survivor Study. Pediatrics, 110, 42–52.
   PubMed Web of Science ®Google Scholar
• Zorrilla, E.P., Luborsky, L., McKay, J.R., Rosenthal, R., Houldin, A., Tax, A., … Schmidt, K. (2001). The relationship of depression and stressors to immunological assays: A meta-analytic review. Brain, Behavior, Immunity, 15, 199–226.
   PubMed Web of Science ®Google Scholar